Quest DiagnosticsDGXEarnings & Financial Report
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX Q3 2025 Key Financial Metrics
Revenue
$2.8B
Gross Profit
$949.0M
Operating Profit
$386.0M
Net Profit
$245.0M
Gross Margin
33.7%
Operating Margin
13.7%
Net Margin
8.7%
YoY Growth
13.2%
EPS
$2.16
Financial Flow
Quest Diagnostics Q3 2025 Financial Summary
Quest Diagnostics reported revenue of $2.8B for Q3 2025, with a net profit of $245.0M (8.7% margin). Cost of goods sold was $1.9B, operating expenses totaled $563.0M.
Key Financial Metrics
| Total Revenue | $2.8B |
|---|---|
| Net Profit | $245.0M |
| Gross Margin | 33.7% |
| Operating Margin | 13.7% |
| Report Period | Q3 2025 |
Quest Diagnostics Annual Revenue by Year
Quest Diagnostics annual revenue history includes year-by-year totals (for example, 2024 revenue was $9.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $9.9B |
| 2023 | $9.3B |
| 2022 | $9.9B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.29B | $2.37B | $2.40B | $2.49B | $2.62B | $2.65B | $2.76B | $2.82B |
| YoY Growth | -1.9% | 1.5% | 2.5% | 8.4% | 14.6% | 12.1% | 15.2% | 13.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.02B | $13.95B | $13.88B | $16.09B | $16.15B | $15.80B | $15.97B | $16.20B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $6.31B | $6.43B | $6.62B | $6.81B | $6.78B | $6.93B | $7.23B | $7.26B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $527.0M | $154.0M | $360.0M | $356.0M | $464.0M | $314.0M | $544.0M | $563.0M |
Other Health Care Companies
CI
Cigna
Revenue
$69.7B
Net Profit
N/A
CVS
CVS Health
Revenue
$105.7B
Net Profit
$2.9B
DVA
DaVita
Revenue
$3.6B
Net Profit
$234.2M
LH
Labcorp
Revenue
$3.6B
Net Profit
$261.1M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B